Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB19384/76Aexternal-prioritypatent/GB1583961A/en
Application filed by Wellcome Foundation LtdfiledCriticalWellcome Foundation Ltd
Publication of ES458639A1publicationCriticalpatent/ES458639A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
A method of preparing prostaglandin derivatives of the formula: *** where R is hydrogen or a pharmacologically acceptable cation, and Z1 and Z2 are individually selected from hydrogen and a blocking group. (Machine-translation by Google Translate, not legally binding)
ES458639A1976-05-111977-05-10A procedure for preparing prostaglandine derivatives. (Machine-translation by Google Translate, not legally binding)
ExpiredES458639A1
(en)
New procedure for obtaining acid salts from addition of 3-phenyl-5-dietilamino-etil-1,2-4, -oxodiazol. (Machine-translation by Google Translate, not legally binding)
A procedure for the preparation of new derivatives of 1-tiazolinil bencimidazoles 5 (6) - substitute. (Machine-translation by Google Translate, not legally binding)